Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01650350
Brief Title: Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer

First Submitted : July 24, 2012
First Submitted that Met QC Criteria : July 24, 2012
First Posted : July 26, 2012 (Estimate)

Results First Submitted : August 14, 2014
Results First Submitted that Met QC Criteria : July 23, 2015
Results First Posted : July 27, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : January 22, 2019
Last Update Posted : February 15, 2019